EA200000081A1 - MALEAT 5- (2-ETHIL-2H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE - Google Patents
MALEAT 5- (2-ETHIL-2H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINEInfo
- Publication number
- EA200000081A1 EA200000081A1 EA200000081A EA200000081A EA200000081A1 EA 200000081 A1 EA200000081 A1 EA 200000081A1 EA 200000081 A EA200000081 A EA 200000081A EA 200000081 A EA200000081 A EA 200000081A EA 200000081 A1 EA200000081 A1 EA 200000081A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tetrahydropyridine
- tetrazol
- methyl
- ethil
- maleat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к соли присоединения малеиновой кислоты 5-(2-этил-2H-тетразол-5-ил)-1-метил-1,2,3,6-тетрагидропиридина, фармацевтическим композициям, содержащим соль присоединения кислоты, и к их использованию для лечения расстройств, вызванных дисфункцией ацетилхолиновой (AcCh) или мускариновой системы.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to the addition salt of maleic acid 5- (2-ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine, pharmaceutical compositions containing an acid addition salt, and to their use for the treatment of disorders caused by acetylcholine dysfunction (AcCh) or the muscarinic system. The international application was published together with an international search report.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200000081A1 true EA200000081A1 (en) | 2000-08-28 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200000081A EA200000081A1 (en) | 1997-07-01 | 1998-07-01 | MALEAT 5- (2-ETHIL-2H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (en) |
| JP (1) | JP2002507215A (en) |
| KR (1) | KR20010014297A (en) |
| CN (1) | CN1261361A (en) |
| AR (1) | AR013096A1 (en) |
| AU (1) | AU735751B2 (en) |
| BG (1) | BG103933A (en) |
| BR (1) | BR9810331A (en) |
| CA (1) | CA2293324A1 (en) |
| CO (1) | CO4940483A1 (en) |
| EA (1) | EA200000081A1 (en) |
| HU (1) | HUP0002876A2 (en) |
| IL (1) | IL133093A0 (en) |
| IS (1) | IS5278A (en) |
| JO (1) | JO2031B1 (en) |
| MA (1) | MA25138A1 (en) |
| NO (1) | NO996580L (en) |
| PE (1) | PE116099A1 (en) |
| PL (1) | PL337184A1 (en) |
| SK (1) | SK187399A3 (en) |
| TN (1) | TNSN98120A1 (en) |
| TR (1) | TR199903283T2 (en) |
| UY (2) | UY25069A1 (en) |
| WO (1) | WO1999001448A1 (en) |
| ZA (1) | ZA985498B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| HUP9901051A2 (en) * | 1995-11-06 | 2000-03-28 | H. Lundbeck A/S | Use of 5-(2-ethyl-2h-tetrazol-5-il)-1,2,3,6-tetrahydro-1-methyl-pyridine for the manufacture of pharmaceutical preparations for the treatment of traumatic brain injury |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002507215A (en) | 2002-03-05 |
| IS5278A (en) | 1999-11-30 |
| BG103933A (en) | 2000-07-31 |
| CN1261361A (en) | 2000-07-26 |
| KR20010014297A (en) | 2001-02-26 |
| AR013096A1 (en) | 2000-12-13 |
| CO4940483A1 (en) | 2000-07-24 |
| UY25177A1 (en) | 2000-12-29 |
| TNSN98120A1 (en) | 2005-03-15 |
| TR199903283T2 (en) | 2000-06-21 |
| HUP0002876A2 (en) | 2001-06-28 |
| IL133093A0 (en) | 2001-03-19 |
| NO996580D0 (en) | 1999-12-30 |
| BR9810331A (en) | 2000-09-05 |
| NO996580L (en) | 1999-12-30 |
| AU8102098A (en) | 1999-01-25 |
| SK187399A3 (en) | 2000-06-12 |
| MA25138A1 (en) | 2001-04-02 |
| AU735751B2 (en) | 2001-07-12 |
| PL337184A1 (en) | 2000-08-14 |
| CA2293324A1 (en) | 1999-01-14 |
| EP0994869A1 (en) | 2000-04-26 |
| ZA985498B (en) | 1999-01-20 |
| WO1999001448A1 (en) | 1999-01-14 |
| PE116099A1 (en) | 1999-11-23 |
| UY25069A1 (en) | 1998-12-21 |
| JO2031B1 (en) | 1999-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200200530A1 (en) | HETEROCYCLIC SUBSTITUTED PYRAZOLONES | |
| EA200100588A1 (en) | PIPERIDINES AS CCR5 MODULATORS | |
| CO4910133A1 (en) | 5-H ANTAGONISTS [1F] | |
| ATE100448T1 (en) | SUBSTITUTED CHINAZOLINONES AS ANGIOTENSIN IIANTAGONISTS. | |
| DE69732490D1 (en) | Monozyclische n-heterozyclische thiosäure derivate als antikoagulans | |
| PT896533E (en) | PENTAFLUOROBENZENOSULFONAMIDAS AND ANALOGOS | |
| PL331634A1 (en) | Bicyclic derivatives of pyrimidine and their application as anticoagulants | |
| DK0807633T3 (en) | Newly known 2,3-disubstituted (5,6) heteroaryl condensed pyrimidin-4-ones | |
| ATE228513T1 (en) | BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACIDS OR CYCLIC HYDROXY ACIDS AND THEIR USE AS ANTICOAGULANTS | |
| ATE265409T1 (en) | BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACIDS AND HYDROXY ACIDS AND THEIR USE AS ANTICOAGULANTS | |
| EA200500172A1 (en) | AZABICYCLIC DERIVATIVES AS ANTAGONISTS OF MUSCARINE RECEPTORS | |
| EA200100516A1 (en) | DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE | |
| EA200501593A1 (en) | AZABICYCLIC DERIVATIVES AS ANTAGONISTS OF MUSCARINE RECEPTOR | |
| DE69514100T2 (en) | SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS | |
| DK0552765T3 (en) | benzimidazoles, pharmaceutical compositions containing them and processes for their preparation | |
| EA200000081A1 (en) | MALEAT 5- (2-ETHIL-2H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE | |
| BR9807312A (en) | (4-Piperidinyl) -1h-2-benzopyran derivatives useful as antipsychotic agents | |
| DE68919280D1 (en) | Alpha-adrenergic receptor antagonists. | |
| PT889044E (en) | DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM | |
| NO880405L (en) | SUBSTITUTED 3-PHENYL-7H-TIAZOLO (3,2-B) (1,2,4) TRIAZIN-7-ONES, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM, AND THEIR USE, AS WELL AS MANUFACTURED BY THE PREFERRED EMBODIMENTS . | |
| DE68919438D1 (en) | Alpha-adrenergic receptor antagonists. | |
| CA2222552A1 (en) | N-oxides as antibacterial agents | |
| DK286090D0 (en) | ALFA-ADRENERGE RECEPTOR ANTAGONISTS | |
| TH51656A (en) | 5- (2-ethyl-2H-tetrazole-5-il) -1-methyl -1,2,3,6-tetrahydropyridine | |
| ID27964A (en) | TURUNA-AZABISIKLOHEPTANA N-SUBSTITUTED, MAKING AND USING IT |